The "Never-Ending" Mouse Models for MLL-Rearranged Acute Leukemia Are Still Teaching Us.
作者信息
Ottersbach Katrin, Sanjuan-Pla Alejandra, Torres-Ruíz Raúl, Bueno Clara, Velasco-Hernández Talia, Menendez Pablo
机构信息
MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Hematology Research Group, IIS La Fe, Valencia, Spain.
出版信息
Hemasphere. 2018 Jun 19;2(4):e57. doi: 10.1097/HS9.0000000000000057. eCollection 2018 Aug.
Abstract
摘要
相似文献
1
The "Never-Ending" Mouse Models for MLL-Rearranged Acute Leukemia Are Still Teaching Us.
Hemasphere. 2018 Jun 19;2(4):e57. doi: 10.1097/HS9.0000000000000057. eCollection 2018 Aug.
2
Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric -Rearranged Acute Lymphoblastic Leukemia.
Biomedicines. 2021 Jun 23;9(7):711. doi: 10.3390/biomedicines9070711.
3
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
J Hematol Oncol. 2016 Mar 12;9:24. doi: 10.1186/s13045-016-0252-7.
4
Decitabine mildly attenuates -rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizer.
EJHaem. 2020 Aug 24;1(2):527-536. doi: 10.1002/jha2.81. eCollection 2020 Nov.
5
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11511-6. doi: 10.1073/pnas.1310144110. Epub 2013 Jun 24.
6
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
Haematologica. 2010 Oct;95(10):1675-82. doi: 10.3324/haematol.2010.023481. Epub 2010 May 21.
7
Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Cancer Lett. 2016 Mar 28;372(2):157-65. doi: 10.1016/j.canlet.2015.12.032. Epub 2016 Jan 11.
8
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction.
Oncogene. 2019 May;38(20):3824-3842. doi: 10.1038/s41388-018-0666-5. Epub 2019 Jan 22.
9
DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy.
PLoS One. 2014 May 23;9(5):e98270. doi: 10.1371/journal.pone.0098270. eCollection 2014.
10
Recurrent mutations in -rearranged acute myeloid leukemia.
Blood Adv. 2018 Nov 13;2(21):2879-2889. doi: 10.1182/bloodadvances.2018019398.
引用本文的文献
1
Only Infant -Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib.
Int J Mol Sci. 2024 Nov 27;25(23):12760. doi: 10.3390/ijms252312760.
2
Defining the fetal origin of MLL-AF4 infant leukemia highlights specific fatty acid requirements.
Cell Rep. 2021 Oct 26;37(4):109900. doi: 10.1016/j.celrep.2021.109900.
3
Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLL-rearranged B cell acute lymphoblastic leukemia.
J Clin Invest. 2021 Jul 1;131(13). doi: 10.1172/JCI138833.
4
The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features.
Cancer Rep (Hoboken). 2019 Oct;2(5):e1207. doi: 10.1002/cnr2.1207. Epub 2019 Aug 7.
5
Mouse Models of Myeloid Malignancies.
Cold Spring Harb Perspect Med. 2021 Jan 4;11(1):a035535. doi: 10.1101/cshperspect.a035535.
6
The Impact of PI3-kinase/RAS Pathway Cooperating Mutations in the Evolution of -rearranged Leukemia.
Hemasphere. 2019 Jun 4;3(3):e195. doi: 10.1097/HS9.0000000000000195. eCollection 2019 Jun.
7
CircRNAs Are Here to Stay: A Perspective on the Recombinome.
Front Genet. 2019 Feb 13;10:88. doi: 10.3389/fgene.2019.00088. eCollection 2019.
本文引用的文献
1
A Novel Inducible Mouse Model of -driven Mixed-lineage Acute Leukemia.
Hemasphere. 2018 Jun 12;2(4):e51. doi: 10.1097/HS9.0000000000000051. eCollection 2018 Aug.
2
leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing.
Blood Adv. 2018 Apr 24;2(8):832-845. doi: 10.1182/bloodadvances.2017013748.
3
The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34 cells.
Oncotarget. 2017 Jul 26;8(47):81936-81941. doi: 10.18632/oncotarget.19567. eCollection 2017 Oct 10.
4
Intratumoral heterogeneity and clonal evolution in blood malignancies and solid tumors.
Oncotarget. 2017 Aug 16;8(39):66742-66746. doi: 10.18632/oncotarget.20279. eCollection 2017 Sep 12.
5
Modeling mixed-lineage-rearranged leukemia initiation in CD34 cells: a "CRISPR" solution.
Haematologica. 2017 Sep;102(9):1467-1468. doi: 10.3324/haematol.2017.173740.
6
Molecular processes involved in B cell acute lymphoblastic leukaemia.
Cell Mol Life Sci. 2018 Feb;75(3):417-446. doi: 10.1007/s00018-017-2620-z. Epub 2017 Aug 17.
7
The MLL recombinome of acute leukemias in 2017.
Leukemia. 2018 Feb;32(2):273-284. doi: 10.1038/leu.2017.213. Epub 2017 Jul 13.
8
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells .
Haematologica. 2017 Sep;102(9):1558-1566. doi: 10.3324/haematol.2017.164046. Epub 2017 Jun 1.
9
Mouse models of MLL leukemia: recapitulating the human disease.
Blood. 2017 Apr 20;129(16):2217-2223. doi: 10.1182/blood-2016-10-691428. Epub 2017 Feb 8.
10
Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy.
Curr Opin Hematol. 2017 Mar;24(2):139-145. doi: 10.1097/MOH.0000000000000322.
Zotero 插件